Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer. (2016)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1517/17425247.2016.1167036
PubMed Identifier: 27080542
Publication URI: http://europepmc.org/abstract/MED/27080542
Type: Journal Article/Review
Volume: 13
Parent Publication: Expert opinion on drug delivery
Issue: 7
ISSN: 1742-5247